Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
48‑Hour “Crisis‑Management” Blueprint Goal: Protect patients, limit legal/financial exposure, preserve the company’s reputation, and keep the board and investors informed—while staying within the regulatory timeline that actually exists (FDA’s 15‑day deadline for serious adverse‑event reports, not the 6‑month “formal”…Read the full answer